|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online January 12, 2006
doi: 10.1242/10.1242/jcs.02734
Research Article |
1 Program in Molecular and Cellular Biology, Department of Pharmacological Sciences, University Medical Center at Stony Brook, Stony Brook, NY 11794-8651, USA
2 Program in Molecular and Cellular Pharmacology, Department of Pharmacological Sciences, University Medical Center at Stony Brook, Stony Brook, NY 11794-8651, USA
* Author for correspondence (e-mail: stella{at}pharm.stonybrook.edu)
Accepted 6 October 2005
Stroke and many neurodegenerative diseases culminate in neuronal death through a mechanism known as excitotoxicity. Excitotoxicity proceeds through a complex signaling pathway that includes the participation of the serine protease tissue plasminogen activator (tPA). tPA mediates neurotoxic effects on resident central nervous system cells as well alters blood-brain barrier (BBB) permeability, which further promotes neurodegeneration. Another signaling molecule that promotes neurodegeneration and BBB dysfunction is nitric oxide (NO), although its precise role in pathological progression remains unclear. We examine here the potentially interrelated roles of tPA, NO and peroxynitrite (ONOO), which is the toxic metabolite of NO, in BBB breakdown and neurodegeneration following intrahippocampal injection of the glutamate analog kainite (KA). We find that NO and ONOO production are linked to tPA-mediated excitotoxic injury, and demonstrate that NO provision suffices to restore the toxic effects of KA in tPA-deficient mice that are normally resistant to excitotoxicity. NO also promotes BBB breakdown and excitotoxicity. Interestingly, BBB breakdown in itself does not suffice to elicit neurodegeneration; a subsequent ONOO-mediated event is required. In conclusion, NO and ONOO function as downstream effectors of tPA-mediated excitotoxicity.
Key words: Blood-brain barrier, Nitric oxide, tPA, Peroxynitrite, Excitotoxicity, Microglia
This article has been cited by other articles:
![]() |
L. Park, E. F. Gallo, J. Anrather, G. Wang, E. H. Norris, J. Paul, S. Strickland, and C. Iadecola Key role of tissue plasminogen activator in neurovascular coupling PNAS, January 22, 2008; 105(3): 1073 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, R. Polavarapu, H. She, Z. Mao, and M. Yepes Tissue-Type Plasminogen Activator and the Low-Density Lipoprotein Receptor-Related Protein Mediate Cerebral Ischemia-Induced Nuclear Factor-{kappa}B Pathway Activation Am. J. Pathol., October 1, 2007; 171(4): 1281 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Parathath, I. Gravanis, and S. E. Tsirka Nitric Oxide Synthase Isoforms Undertake Unique Roles During Excitotoxicity Stroke, June 1, 2007; 38(6): 1938 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Sheehan, C. Zhou, I. Gravanis, A. D. Rogove, Y.-P. Wu, D. F. Bogenhagen, and S. E. Tsirka Proteolytic Activation of Monocyte Chemoattractant Protein-1 by Plasmin Underlies Excitotoxic Neurodegeneration in Mice J. Neurosci., February 14, 2007; 27(7): 1738 - 1745. [Abstract] [Full Text] [PDF] |
||||